Patients First Health Care Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2066 Village Lane, Hermann, MO 65041 Phone: 573-486-5006 |
Hermann Area District Hospital Family Medicine Medicare: Medicare Enrolled Practice Location: 509 West 18th, Hermann, MO 65041 Phone: 573-486-2191 Fax: 573-486-3743 |
Southwest Medical Associates Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 1714 Wein St, Hermann, MO 65041 Phone: 573-486-2118 Fax: 573-486-3533 |
Southwest Medical Associates Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1714 Wein St, Hermann, MO 65041 Phone: 573-486-2118 Fax: 573-486-3533 |
Hermann Medical Arts Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 134 W 6th St, Hermann, MO 65041 Phone: 573-486-5711 Fax: 573-486-3827 |
Hermann Medical Arts Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 134 W 6th St, Hermann, MO 65041 Phone: 573-486-5711 Fax: 573-486-3827 |
News Archive
Halozyme Therapeutics, Inc. today announced the delivery of a notice of breach to Baxter Healthcare Corporation due to Baxter's failure to provide HYLENEX (hyaluronidase human injection) in accordance with the terms of the parties' existing development and supply contracts.
In today's headlines, the 26 states opposed to the health law have filed their Supreme Court arguments against the measure's Medicaid expansion.
SpinalMotion, Inc., developer of the investigational Kineflex® lumbar and Kineflex®|C cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has completed enrollment in an international clinical study evaluating the Kineflex lumbar artificial disc inserted via a minimally invasive lateral approach. The data from the study will be used to support regulatory submissions for international commercialization.
Amerigroup Corporation today announced that net income for the fourth quarter of 2011 was $32.8 million, or $0.67 per diluted share, versus $48.1 million, or $0.96 per diluted share, for the third quarter of 2011.
Hundreds of thousands of HIV-positive people in developing countries in a few years will have no antiretroviral drug treatment unless more focus is placed on drug costs and access, HIV/AIDS advocates said Wednesday at the XVI International AIDS Conference in Toronto, Toronto's Globe and Mail reports.
› Verified 2 days ago